Table 3.
Disease free survival (DFS) | ||||
---|---|---|---|---|
Univariate | Multivariate | |||
HR (95% CI) | P | HR (95% CI) | P | |
Age | ||||
< 65 y | 1 | |||
≥ 65 y | 1.76 (0.97–2.68) | 0.079 | ||
Gender | ||||
Male | 1 | |||
Female | 1.53 (0.93–2.31) | 0.372 | ||
Location | ||||
Left | 1 | |||
Others | 0.74 (0.52–1.39) | 0.354 | ||
T stage | ||||
T1 + T2 | 1 | |||
T3 + T4 | 1.85 (0.56–5.37) | 0.482 | ||
N stage | ||||
N0 | 1 | 1 | ||
N1 + N2 | 5.26 (2.42–10.46) | <0.001* | 4.21 (2.50–7.94) | <0.001* |
AJCC stage | ||||
II | 1 | 1 | ||
III | 6.82 (3.72–10.93) | <0.001* | 2.29 (1.21–3.82) | 0.381 |
Histologic grade | ||||
Well Differentiated | 1 | 1 | ||
Poorly differentiated | 2.83 (1.79–4.29) | <0.001* | 2.20 (1.35–3.62) | 0.282 |
Venous & Lymphatic invasion | ||||
No | 1 | |||
Yes | 0.72 (0.56–1.27) | 0.413 | ||
Peritoneal Dissemination | ||||
Absent | 1 | |||
Present | 0.84 (0.68–1.53) | 0.281 | ||
Liver Metastsis | ||||
Negative | 1 | 1 | ||
Positive Multinodular | 0.52 (0.29–0.83) | 0.003* | 0.69 (0.36–1.23) | 0.032* |
MiR-19b-3p | ||||
Low | 1 | 1 | ||
High | 3.34 (1.97–5.23) | <0.001* | 2.73 (1.76–3.89) | 0.016* |
HR: Hazard ratio; CI: Confidence interval
*P < 0.05 was considered significant